Trade AstraZeneca ^AZN

AstraZeneca, Insitro strike AI drug discovery deal | Fox Business Video

1,227,801 Astrazeneca Plc $AZN Shares Sold by Ninety One UK Ltd

Insitro, AstraZeneca Partner To Develop AI-Discovered Therapies For MASH And Herat Disease

AstraZeneca signs AI drug discovery deal with insitro worth up to $1.86 billion

Astrazeneca Plc $AZN Shares Newly Bought by Ninety One North America Inc. - Stock Observer

Astrazeneca (NYSE:AZN) Stock Rating Raised to Hold at Zacks Research - Markets Daily

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro | Morningstar

Insitro, AstraZeneca Sign AI Drug Discovery Deal

Astrazeneca (NYSE:AZN) Stock Bumped Up to "Hold" by Zacks Research

26,932 Astrazeneca Plc $AZN Shares Purchased by ZWJ Investment Counsel Inc.

Astrazeneca Plc $AZN Stock Sold by Covenant Asset Management LLC - Zolmax

Astrazeneca Plc $AZN Shares Sold by Covenant Asset Management LLC

AstraZeneca strikes $40 million AI drug discovery deal with insitro

AstraZeneca and Insitro Ink $1.86 Billion AI Drug Discovery Deal

Manufacturing Stocks To Watch Today - October 12th - Markets Daily

Erste Group Bank Predicts Stronger Earnings for Astrazeneca - Markets Daily

Astrazeneca Plc (NYSE:AZN) Stock Has Consensus Target Price of $206.67 According to Analysts - Stock Observer

Chronic Kidney Disease Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments - DelveInsight | Tricida, Otsuka Pharmaceuticals, AstraZeneca | ABNewswire

Combination therapy for BCG-unresponsive non-muscle-invasive bladder cancer: biological rationale and ongoing clinical strategies

Endometrial Cancer Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation - DelveInsight | AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott | ABNewswire

Astrazeneca (NYSE:AZN) Shares Up 3.5% - Here's What Happened

Henry James International Management Inc. Sells 13,512 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by Generate Investment Management Ltd

Best Manufacturing Stocks To Keep An Eye On - October 14th - Zolmax

Deals/M&As: Stryker invests $400M in CMR; Enodia-Pfizer $500M pact

ISG Event to Focus on Enterprise Transformations that Deliver AI Success

NIPER Raebareli and AstraZeneca to Expand Clinical Trials to 25 Emerging Hubs

AstraZeneca and NIPER Raebareli Join Forces to Enhance Clinical Research in India, ETPharma

NIPER Raebareli, AstraZeneca partner to expand clinical trials to 25 emerging hubs

Akeso Biopharma: Completed 6th Round of Financing in 6 Years, Raised Additional 1.94 Billion Yuan This Time

Manufacturing Stocks To Watch Today - October 12th - Stock Observer

Best Manufacturing Stocks To Watch Now - October 11th - Daily Political

Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial

Astrazeneca Plc $AZN Shares Sold by Montrusco Bolton Investments Inc. - Stock Observer

Erste Group Bank Expects Increased Earnings for Astrazeneca

Astrazeneca (NYSE:AZN) Rating Lowered to Hold at Wall Street Zen - Markets Daily

Non Alcoholic Fatty Liver Disease Clinical Trial Pipeline Gains Momentum: 90+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire

Greener Pharma Manufacturing Faces the Scale-Up Test

Amid the Biotech Madness, I Spotted an Opening in a Promising Small-Cap

AstraZeneca HPP Drug Shows Gains Despite Missing Key Phase III Endpoint - Stock Observer

Astrazeneca Plc (AZN) - What Are Researchers Saying About This Stock?

AstraZeneca announces ALXN1850 did not achieve statistical significance

NSCLC Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Merck | ABNewswire

Astrazeneca (NYSE:AZN) Downgraded by Wall Street Zen to "Hold"

AZN: Patent Fears Still Matter, New Growth Now Rests On Late Stage Depth

3 British AI Healthcare Stocks With Revenue Growth Up To 14%

Biopharma giant opens $1B Cambridge research hub for nearly 2K scientists, researchers

Death threats by fired AstraZeneca scientist brings jail time - WHYY

AstraZeneca (LON:AZN) Hits New 52-Week Low - What's Next? - Zolmax

AstraZeneca's (AZN) Buy Rating Reiterated at Berenberg Bank

AstraZeneca (LON:AZN) Earns "Buy" Rating from Berenberg Bank - Zolmax

AstraZeneca's (AZN) Buy Rating Reaffirmed at Berenberg Bank - Zolmax

SOPHiA GENETICS (NASDAQ:SOPH) Stock: Insider Zhenyu Xu Sells 7,394 Shares - Daily Political

Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital

Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital

Proteome-guided drug discovery maps and mitigates therapeutic degrader toxicity

Astrazeneca Plc $AZN Stock Bought by Professional Advisory Services Inc. - Zolmax

AstraZeneca (LON:AZN) Given Buy Rating at Jefferies Financial Group - Daily Political

AstraZeneca (LON:AZN) Earns "Buy" Rating from Jefferies Financial Group - Daily Political

AstraZeneca (AZN) Seeks FDA Approval for New Lung Cancer Treatment. Can It Fuel Oncology Growth?

Astrazeneca Plc $AZN Holdings Boosted by Professional Advisory Services Inc. - Daily Political

Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGIS

Astrazeneca Plc $AZN Stock Acquired by Gradient Investments LLC - Stock Observer

SOPHiA GENETICS Partners Myriad Genetics To Advance Prostate Genomic Instability Score Technology

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

AstraZeneca (LON:AZN) Stock Keeps "Buy" Rating at Berenberg Bank

Chemotherapy Group Stuns with Exceptional Performance, Delivering a Crushing Blow to Allist's Global Ambitions

Analyzing Astrazeneca (NYSE:AZN) and Biofrontera (NASDAQ:BFRI) - Daily Political

Head-To-Head Analysis: Vanda Pharmaceuticals (NASDAQ:VNDA) vs. Astrazeneca (NYSE:AZN) - Zolmax

Financial Analysis: Vanda Pharmaceuticals (NASDAQ:VNDA) & Astrazeneca (NYSE:AZN) - Markets Daily

Combined limbal dysmaturation and microcyst like epithelial changes with corneal nerve alterations of a novel anti nectin-4-MMAE antibody drug conjugate

Canandaigua National Bank & Trust Co. Purchases 11,271 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Newly Acquired by Canandaigua National Bank & Trust Co. - Stock Observer

AstraZeneca (LSE:AZN) Stock Looks Reasonable Based On Current Earnings

Deals/M&As: Gate's $870M Lilly deal expansion; Spyglass buys AVS

Summit Therapeutics Stock Has The Bull Case Changed After AstraZeneca Backing

Startup Funding News Today, October 7, 2026: Nous Research, Monid, Multiply Labs, Quanfluence & More

Jefferies Financial Group Reaffirms Buy Rating for AstraZeneca (LON:AZN)

AstraZeneca's Etcamah: A Game-Changer in Breast Cancer Treatment Approved in India, ETPharma

How Investors Are Reacting To Daiichi Sankyo Company (TSE:4568) Expanding Datroway's Oncology Combination Program

AstraZeneca (LON:AZN) Stock Rating Reaffirmed as "Buy" by Berenberg Bank

AstraZeneca PLC (LON:AZN) Stock Has Consensus Price Target of £150 - Markets Daily

AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos

Best Manufacturing Stocks To Watch Today - October 6th - Daily Political

Is this under-the-radar FTSE 250 biotech gem set to soar from £5.43 to £13.92?

Philippines vies for Asia clinical research hub | Daily Tribune

AstraZeneca CEO Pascal Soriot on new Boston site: Faster, better development of new products is the hope

AstraZeneca opens $1 billion R&D center in Massachusetts

Park National Corp OH Purchases 67,214 Shares of Astrazeneca Plc $AZN

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts | Morningstar

Clinical trial experts turn to AI and new partnerships to tackle growing trial complexity

Barclays Sticks to Their Buy Rating for AstraZeneca (AZN)

Meet the UK growth stock that's forecast to climb 35% - and whose boss just bought £7.3m of its shares

DTI, AstraZeneca deepen Philippines clinical | Daily Tribune